Catalyst Wire Dossier Catalyst Wire Dossier

Zolpidem tartrate sublingual tablet 3.5 mg

zolpidem tartrate · Transcept Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Zolpidem tartrate sublingual tablet 3.5 mg, covering 2012-01-20 to 2012-01-20. Get the full timeline:

Most recent: Clinical Trial Update: Driving Performance After Middle of the Night Administration of 3.5 mg Zolpidem Tartrate Sublingual Tablet [Phase 1]

See pricing